These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 36273169)

  • 1. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
    Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
    Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cargo receptor SQSTM1 ameliorates neurofibrillary tangle pathology and spreading through selective targeting of pathological MAPT (microtubule associated protein tau).
    Xu Y; Zhang S; Zheng H
    Autophagy; 2019 Apr; 15(4):583-598. PubMed ID: 30290707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies.
    Akwa Y; Di Malta C; Zallo F; Gondard E; Lunati A; Diaz-de-Grenu LZ; Zampelli A; Boiret A; Santamaria S; Martinez-Preciado M; Cortese K; Kordower JH; Matute C; Lozano AM; Capetillo-Zarate E; Vaccari T; Settembre C; Baulieu EE; Tampellini D
    Autophagy; 2023 Feb; 19(2):660-677. PubMed ID: 35867714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine.
    Cranston AL; Kraev I; Stewart MG; Horsley D; Santos RX; Robinson L; Dreesen E; Armstrong P; Palliyil S; Harrington CR; Wischik CM; Riedel G
    Cell Signal; 2024 Sep; 121():111269. PubMed ID: 38909930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models.
    Wang W; Zhou Q; Jiang T; Li S; Ye J; Zheng J; Wang X; Liu Y; Deng M; Ke D; Wang Q; Wang Y; Wang JZ
    Theranostics; 2021; 11(11):5279-5295. PubMed ID: 33859747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
    Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
    Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
    Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M
    Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
    Hashem J; Hu M; Zhang J; Gao F; Chen C
    Mol Neurobiol; 2021 Aug; 58(8):4122-4133. PubMed ID: 33939165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    Meduri G; Guillemeau K; Daguinot C; Dounane O; Genet M; Ferrara L; Chambraud B; Baulieu EE; Giustiniani J
    J Alzheimers Dis; 2023; 94(1):313-331. PubMed ID: 37248902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Tauopathy-Homing and Autophagy-Activating Nanoassembly for Specific Clearance of Pathogenic Tau in Alzheimer's Disease.
    Sun H; Zhong Y; Zhu X; Liao H; Lee J; Chen Y; Ma L; Ren J; Zhao M; Tu M; Li F; Zhang H; Tian M; Ling D
    ACS Nano; 2021 Mar; 15(3):5263-5275. PubMed ID: 33683854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology.
    Koss DJ; Robinson L; Drever BD; Plucińska K; Stoppelkamp S; Veselcic P; Riedel G; Platt B
    Neurobiol Dis; 2016 Jul; 91():105-23. PubMed ID: 26949217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice.
    Zhong S; Ye J; Deng Y; Zhang M; Zou M; Yao X; Xiao S
    Molecules; 2023 May; 28(9):. PubMed ID: 37175376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
    Qin Y; Zhang Y; Tomic I; Hao W; Menger MD; Liu C; Fassbender K; Liu Y
    J Alzheimers Dis; 2018; 65(1):243-263. PubMed ID: 30010136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.